SLC5A2 and diabetes mellitus: Another study showed that SGLT2 inhibitors significantly reduced diastolic tension in mouse myocardium, with no change in systolic force, regardless of diabetes, suggesting independent effects from diabetic conditions (Pabel et al., 2018).